Skip to search formSkip to main contentSkip to account menu

procathepsin D

Known as: pro-cathepsin D 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The aim of this study was to identify novel biomarkers for the diagnosis of, and potential therapeutic targets for… 
Review
2010
Review
2010
Procathepsin D (pCD) is overexpressed and secreted by cells of various tumor types including breast and lung carcinomas. pCD… 
Review
2009
Review
2009
Over the past decades, the paradigm that lysosomal enzymes participate only in non-specific protein degradation during cell death… 
Review
2008
Review
2008
For the past ten years, our research has been focused on elucidating the mechanism by which procathepsin D (pCD) impacts cancer… 
2007
2007
Procathepsin D (pCD), a zymogen of lysosomal aspartic peptidase cathepsin D, overexpression is correlated with highly invasive… 
2007
2007
Elevated level of procathepsin D (pCD), a zymogen of lysosomal aspartic proteinase cathepsin D, is associated with highly… 
2007
2007
Procathepsin D (pCD) is a major secreted protein in estrogen receptor-positive (ER+) breast cancer cell lines. Several… 
1997
1997
The kinetics of transport and the processing of procathepsin D (proCD), the precursor of a lysosomal aspartyl protease involved…